166 related articles for article (PubMed ID: 23738846)
1. Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapy.
Cervero M; Agud JL; Torres R; García-Lacalle C; Alcázar V; Jusdado JJ; Moreno S
HIV Med; 2013 Oct; 14(9):556-62. PubMed ID: 23738846
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of vitamin D levels among HIV-infected patients in New York City.
Kim JH; Gandhi V; Psevdos G; Espinoza F; Park J; Sharp V
AIDS Res Hum Retroviruses; 2012 Mar; 28(3):235-41. PubMed ID: 21644847
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of vitamin D deficiency and its related risk factor in a Spanish cohort of adult HIV-infected patients: effects of antiretroviral therapy.
Cervero M; Agud JL; García-Lacalle C; Alcázar V; Torres R; Jusdado JJ; Moreno Guillén S
AIDS Res Hum Retroviruses; 2012 Sep; 28(9):963-71. PubMed ID: 22242918
[TBL] [Abstract][Full Text] [Related]
4. Effect of Low Dose Oral Vitamin-D and Calcium Replacement in HIV Patients.
Das S; Bopitya S; Chowdhury AR; Das A; Taha H
Recent Pat Antiinfect Drug Discov; 2016; 11(1):59-67. PubMed ID: 26844688
[TBL] [Abstract][Full Text] [Related]
5. Relationship between vitamin D, parathyroid hormone, bone mineral density, fracture and antiretroviral therapy in HIV patients.
Das S; Bopitya S; Taha H; David L
Recent Pat Antiinfect Drug Discov; 2014; 9(1):6-13. PubMed ID: 24909536
[TBL] [Abstract][Full Text] [Related]
6. Comparison of single and boosted protease inhibitor versus nonnucleoside reverse transcriptase inhibitor-containing cART regimens in antiretroviral-naïve patients starting cART after January 1, 2000.
Mocroft ; Horban ; Clumeck ; Stellbrink ; Monforte dA; Zilmer ; Kirk ; Gatell ; Phillips ; Lundgren ;
HIV Clin Trials; 2006; 7(6):271-84. PubMed ID: 17208897
[TBL] [Abstract][Full Text] [Related]
7. Higher serum 25-hydroxyvitamin D concentrations are associated with active pulmonary tuberculosis in hospitalised HIV infected patients in a low income tropical setting: a cross sectional study.
Musarurwa C; Zijenah LS; Mhandire DZ; Bandason T; Mhandire K; Chipiti MM; Munjoma MW; Mujaji WB
BMC Pulm Med; 2018 May; 18(1):67. PubMed ID: 29739378
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study.
Nylén H; Habtewold A; Makonnen E; Yimer G; Bertilsson L; Burhenne J; Diczfalusy U; Aklillu E
Medicine (Baltimore); 2016 Aug; 95(34):e4631. PubMed ID: 27559961
[TBL] [Abstract][Full Text] [Related]
9. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
[TBL] [Abstract][Full Text] [Related]
10. The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infection.
Paton NI; Stöhr W; Oddershede L; Arenas-Pinto A; Walker S; Sculpher M; Dunn DT
Health Technol Assess; 2016 Mar; 20(21):1-158. PubMed ID: 26986803
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy.
Coelho L; Cardoso SW; Luz PM; Hoffman RM; Mendonça L; Veloso VG; Currier JS; Grinsztejn B; Lake JE
Nutr J; 2015 Aug; 14():81. PubMed ID: 26283663
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Low Dose Oral Vitamin D on Bone Mineral Density Changes in HIV Patients: 36 Months Follow Up.
Dhother J; Bopitiya S; Taha H; Das S
Infect Disord Drug Targets; 2020; 20(5):651-658. PubMed ID: 31258093
[TBL] [Abstract][Full Text] [Related]
13. An oral high dose of cholecalciferol restores vitamin D status in deficient postmenopausal HIV-1-infected women independently of protease inhibitors therapy: a pilot study.
Pepe J; Mezzaroma I; Fantauzzi A; Falciano M; Salotti A; Di Traglia M; Diacinti D; Biondi P; Cipriani C; Cilli M; Minisola S
Endocrine; 2016 Jul; 53(1):299-304. PubMed ID: 26254790
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 replication in central nervous system increases over time on only protease inhibitor therapy.
Donath M; Wolf T; Stürmer M; Herrmann E; Bickel M; Khaykin P; Göpel S; Gute P; Haberl A; de Leuw P; Schüttfort G; Berger A; Stephan C;
Med Microbiol Immunol; 2016 Dec; 205(6):575-583. PubMed ID: 27469377
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D Insufficiency/Deficiency in HIV-Infected Inner City Youth.
Poowuttikul P; Thomas R; Hart B; Secord E
J Int Assoc Provid AIDS Care; 2014; 13(5):438-42. PubMed ID: 23881908
[TBL] [Abstract][Full Text] [Related]
16. Increase of 25-hydroxyvitamin D levels after initiation of combination antiretroviral therapy.
Koga I; Seo K; Yoshino Y; Kitazawa T; Ota Y
J Infect Chemother; 2015 Oct; 21(10):737-41. PubMed ID: 26298041
[TBL] [Abstract][Full Text] [Related]
17. Short communication: Inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users.
Childs KE; Fishman SL; Constable C; Gutierrez JA; Wyatt CM; Dieterich DT; Mullen MP; Branch AD
AIDS Res Hum Retroviruses; 2010 Aug; 26(8):855-9. PubMed ID: 20672993
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of boosted protease inhibitor-based regimens in HIV type 1-infected patients who experienced virological failure with NNRTI-based antiretroviral therapy in a resource-limited setting.
Siripassorn K; Manosuthi W; Chottanapund S; Pakdee A; Sabaitae S; Prasithsirikul W; Tunthanathip P; Ruxrungtham K;
AIDS Res Hum Retroviruses; 2010 Feb; 26(2):139-48. PubMed ID: 20156097
[TBL] [Abstract][Full Text] [Related]
19. Hypovitaminosis D and bone mineral density in human immunodeficiency virus-infected men from India, with or without antiretroviral therapy.
Paul TV; Asha HS; Thomas N; Seshadri MS; Rupali P; Abraham OC; Pulimood SA; Jose A
Endocr Pract; 2010; 16(4):547-53. PubMed ID: 20150027
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risks in Asian HIV-infected patients receiving boosted-protease inhibitor-based antiretroviral treatment.
Ounjaijean S; Kulprachakarn K; Aurpibul L; Kaewpoowat Q; Boonyapranai K; Chaiwarith R; Arwon S; Supparatpinyo K; Rerkasem K
J Infect Dev Ctries; 2021 Mar; 15(2):289-296. PubMed ID: 33690213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
